ASTHO Statement on President Trump's Plan to End the Opioid Epidemic and Address America's "Crisis Next Door" ARLINGTON, VA—Michael Fraser, executive director of ASTHO, issued the ...
ASTHO Statement on FDA’s Announcement to Reduce Nicotine in Cigarettes ARLINGTON, VA—ASTHO’s chief medical officer, Marcus Plescia, issued the following statement on FDA’s announcement to reduce ...
New Opioid Reports Support ASTHO Call for Increased Investment in Prevention ARLINGTON, VA—Two reports released this week highlight the continued need for additional resources to combat the national ...
State Health Officials Commend Public Health Emergency Declaration to Address Opioid Epidemic ARLINGTON, VA—Members of the Association of State and Territorial Health Officials (ASTHO) joined ...
Nation’s Public Health Officials Urge Americans to Stop Vaping ARLINGTON, VA—The Association of State and Territorial Health Officials (ASTHO) issued the following statement in response to the ...
On October 31, 2023 ASTHO announced the approval of one new and four updated health policy statements.
The opioid epidemic has exacerbated the shortage of board-certified forensic pathologists, presenting a major workforce challenge for public health systems.
On Oct. 4, 2023, ASTHO, CDC, the Center for Law and Social Policy, and Mental Health America released a framework for public health leaders with effective strategies to improve mental health and ...
Webinar Series: Leveraging Different Sectors to Address the Youth Mental Health Crisis According to recent data from CDC, poor mental health symptoms and suicidal ideation are on the rise for high ...
On April 12, 2023, ASTHO released a statement applauding the Office of National Drug Control Policy’s announcement designating fentanyl adulterated or associated with xylazine as an emerging drug ...